MEFV rs28942084: What Your Genotype Means
The genetic variant rs28942084 is a well-studied single-nucleotide change located in the MEFV gene, resulting in the amino acid substitution p.Val726Ala. It is primarily recognized as a milder pathogenic allele associated with familial Mediterranean fever (FMF), an autosomal recessive autoinflammatory disorder. Having one copy generally establishes asymptomatic carrier status, although penetrance and symptom severity depend on overall genotype and genetic background.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| TT | You carry two copies of the standard reference allele. This genotype does not convey carrier status or increased genetic risk for MEFV-associated familial Mediterranean fever at this specific locus. It is the most common result found globally. | Informational |
| CT | You carry one copy of the c.2177T>C (p.Val726Ala) variant, establishing carrier status for autosomal recessive familial Mediterranean fever. Most individuals with this genotype are asymptomatic carriers, though reproductive planning and family history may warrant genetic counseling. | Higher attention |
| CC | You carry two copies of the c.2177T>C (p.Val726Ala) variant. This genotype is associated with familial Mediterranean fever, although it frequently displays incomplete penetrance and a milder clinical course compared to other MEFV mutations. | Higher attention |
Genetic Identity and Biological Function
The rs28942084 variant is a missense substitution (c.2177T>C) situated in exon 10 of the MEFV gene on chromosome 16p13.3. This change replaces the amino acid valine with alanine at position 726 (p.Val726Ala) in pyrin, the protein encoded by MEFV. Pyrin is predominantly expressed in immune cells, including granulocytes, monocytes, and dendritic cells, where it serves as an essential regulator of innate immune responses and inflammasome assembly. Under standard physiological conditions, pyrin monitors cellular homeostasis and controls the activation of caspase-1 and subsequent release of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β). The p.Val726Ala alteration subtly destabilizes the autoinhibitory mechanism of pyrin, predisposing the inflammasome to spontaneous activation or heightened inflammatory responses when secondary triggers occur.
Clinical Significance and Disease Association
In clinical databases like ClinVar and biomedical resources such as GeneReviews, rs28942084 is classified as a pathogenic or likely pathogenic variant in the context of classical familial Mediterranean fever (FMF). FMF is characterized by recurrent, self-limiting episodes of fever accompanied by serositis, including peritonitis, pleuritis, or arthritis. Classic FMF follows an autosomal recessive inheritance model, meaning that disease manifestation typically requires two pathogenic MEFV variants (either homozygous or compound heterozygous). Compared to classic severe variants such as p.Met694Val, p.Val726Ala is generally recognized as a milder allele with reduced penetrance. Consequently, individuals who carry two copies of this variant, or this variant paired with another mild variant, often experience less frequent attacks, lower risk of secondary amyloidosis, or may even remain completely asymptomatic throughout life.
Understanding Carrier Status and Monoallelic Expression
An individual with only one copy of rs28942084 (heterozygous genotype) is conventionally classified as an unaffected carrier. Most carriers remain entirely asymptomatic and never develop the characteristic recurrent fevers of FMF. However, peer-reviewed literature notes that a small fraction of individuals carrying a single MEFV variant report mild, occasional autoinflammatory symptoms. Researchers hypothesize that this could be due to subtle gene dosage effects, undetected cryptic mutations elsewhere in the MEFV non-coding regions, or modifying genetic variants within other inflammatory pathways. Despite these occasional mild presentations, a single copy of rs28942084 does not establish a diagnosis of classical FMF. Clinicians emphasize that clinical diagnosis must always be based on observable symptoms, family history, and thorough laboratory evaluation rather than monoallelic carrier findings alone.
Actionable Steps, Limitations, and Clinical Context
Discovering an rs28942084 variant on a direct-to-consumer genetic test provides information regarding carrier status, but it cannot diagnose active disease or predict future symptoms. If you carry this variant and have a personal or family history of unexplained periodic fevers, severe abdominal pain, or joint swelling, a rheumatologist or medical geneticist can provide comprehensive evaluation. For individuals diagnosed with FMF, daily prophylactic therapy with colchicine is standard to prevent attacks and reduce the risk of systemic AA amyloidosis. However, unaffected carriers do not require routine medical treatment. Any questions regarding symptoms, medication, or family planning should be discussed with a certified genetic counselor or physician, as reproductive partners may also choose carrier screening to evaluate the likelihood of transmitting FMF to future children.
How common is this variant?
The rs28942084 variant is most frequent in populations of Middle Eastern descent, with an allele frequency of approximately 0.03 in gnomAD Middle Eastern cohorts, and reaches notable prevalence in Armenian and Arab lineages. In contrast, it is rare in other ancestries, showing an allele frequency of around 0.001 in South Asian populations and near zero in East Asian and Northern European groups.
Frequently asked questions
Does having the rs28942084 variant mean I have familial Mediterranean fever?
No, carrying a single copy of rs28942084 generally means you are a healthy carrier. Familial Mediterranean fever is typically inherited in an autosomal recessive pattern, meaning disease usually requires two altered copies of the MEFV gene.
Can carriers of p.Val726Ala ever experience symptoms?
The vast majority of carriers are asymptomatic. However, medical studies observe that a small minority of heterozygous individuals may report occasional mild inflammatory symptoms, potentially due to undetected secondary variants or other environmental and genetic modifiers.
Why is p.Val726Ala considered a 'milder' variant?
Compared to severe mutations like p.Met694Val, the p.Val726Ala variant shows lower penetrance and milder disease manifestations. Individuals with two copies of this variant often experience less frequent attacks and have a significantly lower baseline risk of developing renal amyloidosis.
Should my family members be tested if I have rs28942084?
If you are planning a family or have relatives with unexplained periodic fevers, sharing your carrier status with a genetic counselor can help determine whether carrier screening for your partner or family members is advisable.
Sources & further reading
Educational information only, last refreshed 9/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs28942084?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29